Arthur Krieg to Morpholinos
This is a "connection" page, showing publications Arthur Krieg has written about Morpholinos.
Connection Strength
0.667
-
Aartsma-Rus A, Krieg AM. FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga. Nucleic Acid Ther. 2017 02; 27(1):1-3.
Score: 0.544
-
Kole R, Krieg AM. Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev. 2015 Jun 29; 87:104-7.
Score: 0.122